Search results for "Phenazine"

showing 10 items of 48 documents

(Dipyrido[3,2-a:2',3'-c]phenazine)(glycinato)copper(II) perchlorate: a novel DNA-intercalator with anti-proliferative activity against thyroid cancer…

2012

Abstract A novel copper(II) heteroleptic complex of dipyrido[3,2-a:2′,3′-c]phenazine (dppz) and glycinato (gly) as chelating ancillary ligand, [Cu(dppz)(gly)]ClO 4 ( 1 ), was synthesized and characterized. X-ray crystallography revealed that the coordination geometry of the cationic [Cu(dppz)(gly)] + unit is hexacoordinated and shows a distorted octahedral coordination geometry in the solid state, with the N,N and N,O chelating atoms of dppz and glycinato, respectively, in the square plane and in which the planar units are connected in a monodimensional polymeric array by the apical copper coordination of the second carboxylic oxygen atom. Biological assays showed that 1 exhibits a remarkab…

Circular dichroismCopper(II) perchlorateStereochemistryIntercalation (chemistry)Phenazinechemistry.chemical_elementAntineoplastic AgentsLigandsBiochemistryInorganic Chemistrychemistry.chemical_compoundCoordination ComplexesCell Line TumorHumansChelationThyroid NeoplasmsDNA CleavageCoordination geometryLigandDNACopper DNA dppz Glycine Intercalation Thyroid cancerCopperIntercalating AgentschemistrySettore CHIM/03 - Chimica Generale E Inorganicaxray cristallogrphyPhenazinesJournal of inorganic biochemistry
researchProduct

The interaction of native calf thymus DNA with FeIII-dipyrido[3,2-a:2’,3’-c]phenazine

2008

The mono and bis dipyrido[3,2-a:2',3'-c]phenazine (dppz) adducts of iron(III) chloride, i.e. [Fe(dppz)]Cl(3) and [Fe(dppz)(2)]Cl(3), have been synthesized and characterized. The interaction of the Fe(III)dppz hydrolyzed aquo complex with native calf thymus DNA has been monitored as a function of the metal complex-DNA molar ratio, by variable temperature UV absorption spectrophotometry, circular dichroism (CD) and fluorescence spectroscopy. The results obtained in solution at various ionic strength values give support for a tight intercalative binding of the Fe(III)dppz cation with DNA. In particular, the appearance of induced CD bands, caused by the addition of Fe(III)dppz, indicate the exi…

Circular dichroismDNA dppz Intercalation Iron SpectroscopyIntercalation (chemistry)PhenazinePhotochemistryNucleic Acid DenaturationBiochemistryFerric CompoundsFluorescenceAdductInorganic ChemistryMetalchemistry.chemical_compoundDNA AdductsMetal aquo complexChemistryCircular DichroismDNABinding constantCrystallographyIonic strengthSettore CHIM/03 - Chimica Generale E Inorganicavisual_artvisual_art.visual_art_mediumPhenazines
researchProduct

Vibrio ponticus sp. nov., a neighbour of V fluvialis-V. furnissii clade, isolated from gilthead sea bream, mussels and seawater.

2004

A new Vibrio species, Vibrio ponticus, is proposed to accommodate four marine bacteria isolated from sea water, mussels and diseased sea bream (Sparus aurata), at the Mediterranean coast of Spain. Strains are Gram negative, slightly halophilic bacteria that require Na+ ion for growth, oxidase and catalase positive, negative for arginine dihydrolase and ornithine decarboxylase but positive for lysine decarboxylase and indole, and utilize beta-hydroxybutyrate as a sole carbon source. Phylogenetic analysis locate these marine bacteria in the vicinity of the V. fluvialis-V. furnissii clade, sharing with these two species 16S rDNA sequence similarities slightly above 97% (97.1 and 97.3%, respect…

DNA BacterialIndolesCarboxy-LyasesHydrolasesMolecular Sequence DataBiologyOrnithine DecarboxylaseApplied Microbiology and BiotechnologyMicrobiologyDNA RibosomalMicrobiologyMarine bacteriophageVibrionaceaeVibrio InfectionsRNA Ribosomal 16SSequence Homology Nucleic AcidMediterranean SeaAnimalsSeawaterRibosomal DNAEcology Evolution Behavior and SystematicsPhylogenyVibrioLysine decarboxylase3-Hydroxybutyric AcidFatty AcidsNucleic Acid HybridizationSequence Analysis DNA16S ribosomal RNAbiology.organism_classificationCatalaseVibrioSea BreamBivalviaSpainVibrio InfectionsPhenazinesGentian VioletOxidoreductasesBacteriaSystematic and applied microbiology
researchProduct

Therapeutic Monitoring of Aripiprazole by HPLC with Column-Switching and Spectrophotometric Detection

2005

Aripiprazole is a novel atypical antipsychotic drug for the treatment of schizophrenia and schizoaffective disorders (1)(2)(3). The drug is metabolized by the cytochrome P450 isoenzymes 3A4 and 2D6 (4). Because of high interindividual variability in the expression of these enzymes, the aripiprazole concentration varies among healthy individuals after administration of the drug (5). In patients, insufficient response or side effects, such as somnolence, akathisia, or nausea, may result from too low or too high drug concentrations. Therapeutic drug monitoring (TDM), which is established practice for many antipsychotic drugs (6)(7), may be helpful for patients treated with aripiprazole. We mea…

DrugPerphenazinemedicine.drug_classmedia_common.quotation_subjectClinical BiochemistryAripiprazoleAtypical antipsychoticQuinolonesPharmacologyPartial agonistHigh-performance liquid chromatographyPiperazinesmedicineHumansChromatography High Pressure Liquidmedia_commonmedicine.diagnostic_testChemistryReboxetineBiochemistry (medical)Therapeutic drug monitoringSchizophreniaSpectrophotometry UltravioletAripiprazoleDrug MonitoringAntipsychotic Agentsmedicine.drugClinical Chemistry
researchProduct

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates.

2004

Abstract The pharmacokinetics of antipsychotic drugs has become an integral part in understanding their pharmacodynamic activity and clinical effects. In addition to metabolism aspects, carrier-mediated transport, particularly secretion by ABC transporters, has been discussed as potentially relevant for this group of therapeutics. In this study, the psychoactive compounds perphenazine, flupentixol, domperidone, desmethyl clozapine, haloperidol, fluphenazine, fluvoxamine, olanzapine, levome-promazine, perazine, desmethyl perazine, clozapine, quetiapine and amisulpride were characterized in terms of P-glycoprotein (P-gp) affinity and transport. Experimental methods involved a radioligand disp…

FluphenazineMalePerphenazineATP Binding Cassette Transporter Subfamily BPharmaceutical SciencePharmacologySubstrate Specificitychemistry.chemical_compoundPharmacokineticsmedicineFluphenazineAnimalsHumansDrug InteractionsTissue DistributionAmisulprideClozapinePharmacologyBrainPerazineFlupentixolRatschemistryCyclosporineAmisulprideCaco-2 CellsSulpirideImmunosuppressive Agentsmedicine.drugTalinololAntipsychotic AgentsThe Journal of pharmacy and pharmacology
researchProduct

Antidepressants and Antipsychotic Drugs Colocalize with 5-HT(3) Receptors in Raft-Like Domains

2005

Despite different chemical structure and pharmacodynamic signaling pathways, a variety of antidepressants and antipsychotics inhibit ion fluxes through 5-HT3receptors in a noncompetitive manner with the exception of the known competitive antagonists mirtazapine and clozapine. To further investigate the mechanisms underlying the noncompetitive inhibition of the serotonin-evoked cation current, we quantified the concentrations of different types of antidepressants and antipsychotics in fractions of sucrose flotation gradients isolated from HEK293 (human embryonic kidney 293) cells stably transfected with the 5-HT3Areceptor and of N1E-115 neuroblastoma cells in relation to the localization of …

Fluphenazinemedicine.medical_specialtyPharmacology5-HT3 receptorCell LineMembrane MicrodomainsDesipramineInternal medicinemedicineHumansSerotonin 5-HT3 Receptor AntagonistsReceptorClozapine5-HT receptorbiologyChemistryGeneral NeuroscienceAntidepressive AgentsEndocrinologybiology.proteinSerotoninSerotonin AntagonistsSignal transductionReceptors Serotonin 5-HT3medicine.drugCellular/MolecularAntipsychotic AgentsProtein Binding
researchProduct

Extrapyramidal Symptoms and their Relationship to Clinical Efficacy under Perphenazine Treatment*

1991

In order to verify the hypothesis of a strict relationship between clinical improvement and extrapyramidal side-effects, especially micrographia, twenty-two acutely ill schizophrenics were treated with perphenazine in a controlled prospective 28-day trial. During the study period, psychopathometric data, prolactin plasma levels, and handwriting samples were collected. According to the remission criteria fixed before the study began (both BPRS ≤ 25 and GAS ≥ 80 points), 45.5% (10/22) of the total patient sample were classified as treatment responders. Handwriting tests were quantified in 21 patients. "Positive" handwriting results, i. e., a reduction of at least 13% in the overall area of 50…

GynecologyPerphenazinemedicine.medical_specialtyGeneral MedicinePsychiatry and Mental healthExtrapyramidal symptomsHandwritingmedicinePharmacology (medical)Clinical efficacymedicine.symptomPsychologyNeurosciencemedicine.drugPharmacopsychiatry
researchProduct

Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells

2015

In recent years, mesoporous silica nanoparticles (MSNs) have been used as effective supports for the development of controlled-release nanodevices that are able to act as multifunctional delivery platforms for the encapsulation of therapeutic agents, enhancing their bioavailability and overcoming common issues such as poor water solubility and poor stability of some drugs. In particular, redox-responsive delivery systems have attracted the attention of scientists because of the intracellular reductive environment related to a high concentration of glutathione (GSH). In this context, we describe herein the development of a GSH-responsive delivery system based on poly(ethylene glycol)- (PEG-)…

INGENIERIA DE LA CONSTRUCCIONCell SurvivalIntracellular SpaceNanoparticleNanotechnologyAntineoplastic AgentsCONTROLLED-RELEASETRIGGERED RELEASEPolyethylene Glycolschemistry.chemical_compoundINORGANIC NANOPARTICLESQUIMICA ORGANICASYSTEMSPEG ratioQUIMICA ANALITICAElectrochemistrymedicinePOLYMER HYBRID NANOPARTICLESGLUTATHIONEBIOQUIMICA Y BIOLOGIA MOLECULARHumansGeneral Materials ScienceDoxorubicinSpectroscopyDrug CarriersENHANCED PERMEABILITYQUIMICA INORGANICASurfaces and InterfacesGlutathioneIN-VITROMesoporous silicaCondensed Matter PhysicsSilicon DioxideControlled releaseGUEST MOLECULESBioavailabilityDrug LiberationchemistryDoxorubicinDelayed-Action PreparationsDrug DesignNanoparticlesPhenazinesSUPPORTSEthylene glycolOxidation-ReductionPorositymedicine.drugHeLa Cells
researchProduct

Towards chemical communication between gated nanoparticles.

2014

The design of comparatively simple and modularly configurable artificial systems able to communicate through the exchange of chemical messengers is, to the best of our knowledge, an unexplored field. As a proof-of-concept, we present here a family of nanoparticles that have been designed to communicate with one another in a hierarchical manner. The concept involves the use of capped mesoporous silica supports in which the messenger delivered by a first type of gated nanoparticle is used to open a second type of nanoparticle, which delivers another messenger that opens a third group of gated nanoobjects.We believe that the conceptual idea that nanodevices can be designed to communicate with …

INGENIERIA DE LA CONSTRUCCIONGovernmentQUIMICA INORGANICALibrary scienceNanotechnologyGeneral ChemistryNanoparticles communityChemical communicationSilicon DioxideChemical communicationMesoporous materialsCatalysisGated nanoparticlesQUIMICA ORGANICADrug Delivery SystemsPolitical scienceQUIMICA ANALITICANanoparticlesNanotechnologyPhenazinesChristian ministryIndicators and ReagentsColoring AgentsPorosityAngewandte Chemie (International ed. in English)
researchProduct

Capping N‐Donor Ligands Modulate the Magnetic Dynamics of Dy III β‐Diketonate Single‐Ion Magnets with D 4 d Symmetry

2019

A family of four mononuclear DyIII β-diketonate complexes with formulas [Dy(tmhd)3 (Br2 -bpy) (1), [Dy(tmhd)3 (Br-bpy)] (2), [Dy(tmhd)3 (dppz)] (3), and [Dy(tmhd)3 (mcdpq)] (4) (tmhd=2,2,6,6-tetramethyl-3,5-heptanedione, Br2 -bpy=5,5'-dibromo-2,2'-bipyridine, Br-bpy=5-bromo-2,2'-bipyridine, dppz=dipyrido [3,2-a:2',3'-c]phenazine, mcdpq=2-methoxyl-3-cyanodipyrido[3,2-f:2,3'-h]quinoxaline) were prepared by modifying the capping N-donor coligands. DyIII centers in these complexes feature an N2 O6 octacoordinate environment with distorted square-antiprismatic D4d symmetry. Magnetic investigations evidenced single-ion magnet behavior in all complexes with energy barriers Ueff of 42.10 (1), 61.47…

Lanthanide010405 organic chemistryChemistryOrganic ChemistryIntermolecular forcePhenazineGeneral Chemistry010402 general chemistry01 natural sciencesCatalysisSymmetry (physics)0104 chemical scienceschemistry.chemical_compoundBipyridineCrystallographyQuinoxalineMagnetCoordination geometryChemistry – A European Journal
researchProduct